Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

U.S. pre-market indices rise, Ralph Lauren and Biogen post strong earnings

EditorVenkatesh Jartarkar
Published 11/08/2023, 01:03 PM
© Reuters.

Today, U.S. pre-market indices recorded gains, with Dow, S&P 500, Nasdaq, and Russell 2000 all on the upswing. This marks the longest winning streak for the Dow since July. Additionally, Wholesale Inventories for September showed an improvement to a neutral 0.0%, putting an end to a previously negative trend.

Fashion company Ralph Lauren (NYSE: NYSE:RL) posted robust fiscal Q2 results today, surpassing estimates on both earnings and sales. The company reported an addition of 1.3 million new Direct-To-Consumer (DTC) subscribers in the quarter and observed a 2% increase in its share price. The company has maintained its full-year guidance.

Biogen Inc. (NASDAQ: NASDAQ:BIIB) also reported strong Q3 earnings and revenues this morning. The company's Multiple Sclerosis (MS) product line significantly contributed to its revenue. Despite receiving FDA approvals for treatments for ALS and Alzheimer's diseases, shares of Biogen remain down single-digits year to date.

However, not all companies enjoyed positive results today. Warner Bros. Discovery (NASDAQ: NASDAQ:WBD) fell short of its bottom-line estimate but surpassed revenue expectations for the quarter, despite losing 700K subscribers. The company's shares are down by 12% in early trading today. This is despite the success of the "Barbie" movie which has grossed $1.5 billion since its release.

Investors will be looking forward to later today when earnings results from The Walt Disney (NYSE:DIS) Co., Arm Holdings (NASDAQ:ARM), and MGM Resorts (NYSE:MGM) among others are expected to be released.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.